Phenylephrine is a decongestant used to relieve nasal congestion and stuffiness caused by colds, allergies, or sinus problems. It can also be used as a nasal spray or eye drops to reduce redness in the eyes.[2] Neo-Synephrine is currently approved and in use across 34 indications[4].[1]
Neo-Synephrine is one of 700 small molecule programs targeting Hypotension. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
206 competitors in Heart Failure
Neo-Synephrine
Brethine
Medrol
Activase
Zemplar
Savaysa
Xifaxan
Potassium Iodide
Oraverse
Xylocaine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Mar 21, 2013
PHENYLEPHRINE HYDROCHLORIDE
NDA NDA203510
Jun 27, 2014
VAZCULEP
NDA NDA204300
Jan 15, 2015
PHENYLEPHRINE HYDROCHLORIDE
NDA NDA207926
Oct 21, 2019
BIORPHEN
NDA NDA212909
Mar 9, 2023
IMMPHENTIV
NDA NDA203826
May 30, 2025
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
NDA NDA216830
Sources
Details